Lv3
268 积分 2022-10-26 加入
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
4天前
已完结
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
4天前
已完结
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies
4天前
已完结
Activation of RAS/MEK/ERK signalling drives biliary differentiation in primary liver cancer
4天前
已完结
Cryoablation induces abscopal immunity in intrahepatic cholangiocarcinoma
4天前
已完结
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
4天前
已完结
Tumour-autonomous IL-6 signalling creates a metabolic vulnerability in intrahepatic cholangiocarcinoma
4天前
已完结
Norepinephrine promotes tumour cell aggressiveness and NK cell ferroptosis via ADRB2 in intrahepatic cholangiocarcinoma with perineural invasion
4天前
已完结
SIRT6 promotes intrahepatic cholangiocarcinoma development by reprogramming glutamine metabolism via enhanced GLUL
4天前
已完结
Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancers
4天前
已完结
皖公网安备34019202002308
